Cambridge Investment Research Advisors, Inc.
Position in ABBV — AbbVie Inc.
CIK 1419186
FAIRFIELD, IA
Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$142,524,114
+$22,400,038 QoQ
Shares Held
566,381
+2.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#202
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. ABBV ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,524,114 | 566,381 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $120,124,076 | 552,320 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $124,576,632 | 545,217 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $123,979,482 | 535,456 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $96,855,216 | 521,793 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $107,077,291 | 511,060 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $87,039,414 | 489,811 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,766,621 | 495,071 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $81,860,835 | 477,267 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $87,264,141 | 479,210 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $75,585,377 | 487,742 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $79,408,435 | 532,728 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $68,582,285 | 509,035 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $82,728,170 | 519,095 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $88,226,616 | 545,923 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $71,888,110 | 535,639 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $78,543,358 | 512,819 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $87,142,392 | 537,551 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $70,971,128 | 524,159 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $57,519,088 | 533,226 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $57,883,105 | 513,877 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $52,676,085 | 486,750 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $46,344,946 | 432,524 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $38,951,185 | 444,699 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $40,625,607 | 413,787 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $28,433,117 | 373,187 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||